Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aldeyra, Alphamab, Alterity, Anaveon, Arbutus, Journey, Lipella, Oculis, Olipass, Purple, Pyxis, Tonix, Trethera.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioventrix, Tandem Diabetes Care.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bellicum, Cantargia, Dermavant, Direct, Epicentrx, Evecxia, Horizon, Index, Inhibikase, Mabwell, Oryzon, Oxurion, Protagonist, Recode, Stoke.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Vomaris Innovations.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB, Acesion, Akeso, Astellas, Atea, Biohaven, Cantargia, Endo, Gradalis, Immutep, Medivir, Puma, Reneo, Servier, Telix, Tscan.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Astellas, Astrazeneca, Ausperbio, Bionomics, Biothera Solutions, Daiichi Sankyo, Dyadic, Genfleet, Harbour, Immunovant, Innocare, JW.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acarix, Dariohealth, Photocure, Spire.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alx, Alzecure, Aridis, Asahi, Biothera, Biovie, Boan, Calliditas, Gensight, Isotope, Luye, Pliant, Vectivbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Terumo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anheart, Ausper, First Wave, Iliad, Innocare, Merck & Co., Palvella.